相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (vol 17, pg 954, 2018)
Ali H. Mokdad
LANCET NEUROLOGY (2021)
Migraine: integrated approaches to clinical management and emerging treatments
Messoud Ashina et al.
LANCET (2021)
Migraine: disease characterisation, biomarkers, and precision medicine
Messoud Ashina et al.
LANCET (2021)
Migraine: epidemiology and systems of care
Messoud Ashina et al.
LANCET (2021)
Tension-type headache
Sait Ashina et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Predictors of episodic migraine transformation to chronic migraine: A systematic review and meta-analysis of observational cohort studies
Jingjing Xu et al.
CEPHALALGIA (2020)
Efficacy of galcanezumab in patients with episodic migraine and a history of preventive treatment failure: results from two global randomized clinical trials
D. D. Ruff et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Neuroimaging for Migraine: The American Headache Society Systematic Review and Evidence-Based Guideline
Randolph W. Evans et al.
HEADACHE (2020)
The Risks or Lack Thereof of Migraine Treatments in Vascular Disease
Hans-Christoph Diener
HEADACHE (2020)
European Academy of Neurology guideline on the management of medication-overuse headache
H. C. Diener et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review
Nada Ahmad Hindiyeh et al.
HEADACHE (2020)
Comparison of 3 Treatment Strategies for Medication Overuse Headache A Randomized Clinical Trial
Louise Ninett Carlsen et al.
JAMA NEUROLOGY (2020)
Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials
Uwe Reuter et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Valery L. Feigin et al.
LANCET NEUROLOGY (2019)
Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis
Jeffrey L. Jackson et al.
PLOS ONE (2019)
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
Peter J. Goadsby et al.
BRAIN (2019)
Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications
Thomas Dresler et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Aids to management of headache disorders in primary care (2nd edition): on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache
T. J. Steiner et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Pathophysiology, prevention, and treatment of medication overuse headache
Hans-Christoph Diener et al.
LANCET NEUROLOGY (2019)
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine
Richard B. Lipton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Unmet Acute Treatment Needs From the 2017 Migraine in America Symptoms and Treatment Study
Richard B. Lipton et al.
HEADACHE (2019)
Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial
Michel D. Ferrari et al.
LANCET (2019)
Migraine and the trigeminovascular system-40 years and counting
Messoud Ashina et al.
LANCET NEUROLOGY (2019)
Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society
Maryam Oskoui et al.
NEUROLOGY (2019)
Practice guideline update summary: Acute treatment of migraine in children and adolescents Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society
Maryam Oskoui et al.
NEUROLOGY (2019)
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine The ACHIEVE II Randomized Clinical Trial
Richard B. Lipton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Targeting calcitonin gene-related peptide: a new era in migraine therapy
Andrew Charles et al.
LANCET (2019)
Sleep Disorders Among People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
Dawn C. Buse et al.
HEADACHE (2019)
Migraine Progression: A Systematic Review
Dawn C. Buse et al.
HEADACHE (2019)
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
Simona Sacco et al.
JOURNAL OF HEADACHE AND PAIN (2019)
Red and orange flags for secondary headaches in clinical practice: SNNOOP10 list
Thien Phu Do et al.
NEUROLOGY (2019)
Flunarizine as prophylaxis for episodic migraine: a systematic review with meta-analysis
Anker Stubberud et al.
PAIN (2019)
Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial
Udith A. Pijpers et al.
BRAIN (2019)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Effect of Age-Related Factors on the Pharmacokinetics of Lamotrigine and Potential Implications for Maintenance Dose Optimisation in Future Clinical Trials
Sven C. van Dijkman et al.
CLINICAL PHARMACOKINETICS (2018)
Increased pain sensitivity in migraine and tension-type headache coexistent with low back pain: A cross-sectional population study
S. Ashina et al.
EUROPEAN JOURNAL OF PAIN (2018)
Poor medical care for people with migraine in Europe - evidence from the Eurolight study
Zaza Katsarava et al.
JOURNAL OF HEADACHE AND PAIN (2018)
The headache under-response to treatment (HURT) questionnaire, an outcome measure to guide follow-up in primary care: development, psychometric evaluation and assessment of utility
T. J. Steiner et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation
Efstratia Vatzaki et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
Lars Bendtsen et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Paediatric migraine: evidence-based management and future directions
Serena L. Orr et al.
NATURE REVIEWS NEUROLOGY (2018)
Triggers, Protectors, and Predictors in Episodic Migraine
Michael J. Marmura
CURRENT PAIN AND HEADACHE REPORTS (2018)
The validation of the Hungarian version of the ID-migraine questionnaire
Eva Csepany et al.
JOURNAL OF HEADACHE AND PAIN (2018)
Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
Uwe Reuter et al.
LANCET (2018)
Biological insights from the premonitory symptoms of migraine
Nazia Karsan et al.
NATURE REVIEWS NEUROLOGY (2018)
Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Joseph Raymond Zunt et al.
LANCET NEUROLOGY (2018)
Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Lars Jacob Stovner et al.
LANCET NEUROLOGY (2018)
Incidental Findings and Normal Anatomical Variants on MRI of the Brain in Adults for Primary Headaches
Randolph W. Evans
HEADACHE (2017)
Fluctuations in episodic and chronic migraine status over the course of 1 year: implications for diagnosis, treatment and clinical trial design
Daniel Serrano et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Prognostic factors for chronic headache A systematic review
Katrin Probyn et al.
NEUROLOGY (2017)
Drugs for the acute treatment of migraine in children and adolescents
Alexandra J. Faber et al.
PAEDIATRICS & CHILD HEALTH (2017)
Efficacy of interventions used by physiotherapists for patients with headache and migraine-systematic review and meta-analysis
Kerstin Luedtke et al.
CEPHALALGIA (2016)
European headache federation consensus on technical investigation for primary headache disorders
D. D. Mitsikostas et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Brief intervention by general practitioners for medication-overuse headache, follow-up after 6 months: a pragmatic cluster-randomised controlled trial
Espen Saxhaug Kristoffersen et al.
JOURNAL OF NEUROLOGY (2016)
Headache, depression and anxiety: associations in the Eurolight project
Christian Lampl et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Psychological interventions for migraine: a systematic review
Andrew Sullivan et al.
JOURNAL OF NEUROLOGY (2016)
The migraine postdrome An electronic diary study
Nicola J. Giffin et al.
NEUROLOGY (2016)
Pharmacological treatment of migraine during pregnancy and breastfeeding
Siri Amundsen et al.
NATURE REVIEWS NEUROLOGY (2015)
Prevalence of neck pain in migraine and tension-type headache: A population study
Sait Ashina et al.
CEPHALALGIA (2015)
Late-life migraine accompaniments: A narrative review
Kiratikorn Vongvaivanich et al.
CEPHALALGIA (2015)
Adherence to oral migraine-preventive medications among patients with chronic migraine
Zsolt Hepp et al.
CEPHALALGIA (2015)
Brief intervention for medication-overuse headache in primary care. The BIMOH study: a double-blind pragmatic cluster randomised parallel controlled trial
Espen Saxhaug Kristoffersen et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Prevalence of menstrual migraine: A population-based study
Kjersti G. Vetvik et al.
CEPHALALGIA (2014)
A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study
Lars J. Stovner et al.
CEPHALALGIA (2014)
Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment
Stephen Silberstein et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Methodological Issues in Studying Trigger Factors and Premonitory Features of Migraine
Richard B. Lipton et al.
HEADACHE (2014)
Should we educate about the risks of medication overuse headache?
James T. F. Lai et al.
JOURNAL OF HEADACHE AND PAIN (2014)
Headaches and Neuroimaging: High Utilization and Costs Despite Guidelines
Brian C. Callaghan et al.
JAMA INTERNAL MEDICINE (2014)
The Headache Under-Response to Treatment (HURT) Questionnaire: Assessment of utility in headache specialist care
Maria L. S. Westergaard et al.
CEPHALALGIA (2013)
Metoclopramide in Pregnancy and Risk of Major Congenital Malformations and Fetal Death
Bjorn Pasternak et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
HURT (Headache Under-Response to Treatment) questionnaire in the management of primary headache disorders: reliability, validity and clinical utility of the Arabic version
Mohammed Al Jumah et al.
JOURNAL OF HEADACHE AND PAIN (2013)
Acute treatment optimization for migraine: results of the American migraine prevalence and prevention (AMPP) study
R. B. Lipton et al.
JOURNAL OF HEADACHE AND PAIN (2013)
Early dosing and efficacy of triptans in acute migraine treatment: the TEMPO study
M. Lanteri-Minet et al.
CEPHALALGIA (2012)
Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study
Dawn C. Buse et al.
HEADACHE (2012)
Chronic migraine-classification, characteristics and treatment
Hans-Christoph Diener et al.
NATURE REVIEWS NEUROLOGY (2012)
Migraine headache is present in the aura phase A prospective study
Jakob M. Hansen et al.
NEUROLOGY (2012)
Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society
S. D. Silberstein et al.
NEUROLOGY (2012)
Unusual Headaches in the Elderly
Cynthia C. Bamford et al.
CURRENT PAIN AND HEADACHE REPORTS (2011)
Are Menstrual and Nonmenstrual Migraine Attacks Different?
Kjersti Grotta Vetvik et al.
CURRENT PAIN AND HEADACHE REPORTS (2011)
Neurophysiological tests and neuroimaging procedures in non-acute headache (2nd edition)
G. Sandrini et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Amitriptyline in the Prophylactic Treatment of Migraine and Chronic Daily Headache
James R. Couch
HEADACHE (2011)
What do the patients with medication overuse headache expect from treatment and what are the preferred sources of information?
S. B. Munksgaard et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Recommendations for headache service organisation and delivery in Europe
T. J. Steiner et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Global prevalence of chronic migraine: A systematic review
J. L. Natoli et al.
CEPHALALGIA (2010)
Validation of the Portuguese Version of ID-Migraine™
Raquel Gil-Gouveia et al.
HEADACHE (2010)
Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
D. C. Buse et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)
Current approaches to the diagnosis and management of paediatric migraine
Andrew D. Hershey
LANCET NEUROLOGY (2010)
Tricyclic antidepressants and headaches: systematic review and meta-analysis
Jeffrey L. Jackson et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Temporomandibular disorders and cutaneous allodynia are associated in individuals with migraine
D. B. Grossi et al.
CEPHALALGIA (2009)
Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies
S. Evers et al.
CEPHALALGIA (2009)
Topiramate Versus Amitriptyline in Migraine Prevention: A 26-Week, Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Noninferiority Trial in Adult Migraineurs
David W. Dodick et al.
CLINICAL THERAPEUTICS (2009)
Topiramate Treatment of Chronic Migraine: A Randomized, Placebo-Controlled Trial of Quality of Life and Other Efficacy Measures
Stephen Silberstein et al.
HEADACHE (2009)
Migraine frequency and risk of cardiovascular disease in women
Tobias Kurth et al.
NEUROLOGY (2009)
Excessive opioid use and the development of chronic migraine
Marcelo E. Bigal et al.
PAIN (2009)
History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward
P. C. Tfelt-Hansen et al.
CEPHALALGIA (2008)
Early vs. non-early intervention in acute migraine - 'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan
P. J. Goadsby et al.
CEPHALALGIA (2008)
The incidence and prevalence of cluster headache: a meta-analysis of population-based studies
M. Fischera et al.
CEPHALALGIA (2008)
Pregnancy plus - Migraine in pregnancy
Peter J. Goadsby et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Current concepts - Computed tomography - An increasing source of radiation exposure
David J. Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Assessment of headache diagnosis. A comparative population study of a clinical interview with a diagnostic headache diary
D. Phillip et al.
CEPHALALGIA (2007)
Age-dependent prevalence and clinical features of migraine
Marcelo E. Bigal et al.
NEUROLOGY (2006)
Obesity is a risk factor for transformed migraine but not chronic tension-type headache
Marcelo E. Bigal et al.
NEUROLOGY (2006)
Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial
HC Diener et al.
LANCET NEUROLOGY (2006)
Infrequent or non-response to oral sumatriptan does not predict response to other triptans -: review of four trials
CGH Dahlöf
CEPHALALGIA (2006)
Development and validation of the migraine screen questionnaire (MS-Q)
MJA Láinez et al.
HEADACHE (2005)
A self-administered screener for migraine in primary care -: The ID Migraine™ validation study
RB Lipton et al.
NEUROLOGY (2003)
Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan
M Färkkilä et al.
CEPHALALGIA (2003)
Prophylactic treatment of migraine with an angiotensin II receptor blocker - A randomized controlled trial
E Tronvik et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Naratriptan as short-term prophylaxis of menstrually associated migraine:: A randomized, double-blind, placebo-controlled study
L Newman et al.
HEADACHE (2001)